China’s AI drug-discovery champion sees survival as the biggest challenge
By Chen Guangjing Do China’s AI drug discovery champions need to worry about survival? For Wen…
Eli Lilly bets $2.75 billion on Insilico Medicine: is this AI drug discovery’s ‘GPT moment’?
By Hualin Wuwang Another traditional industry has officially fallen for AI. On March 29, US pharmaceutical…
Biotech startup METiS Therapeutics plans Hong Kong IPO with AI-driven drug delivery revolution
By Da Cheung METiS Therapeutics, a drug discovery and delivery biotech, has received the regulatory green light…
Latest
- Han’s CNC rides AI infrastructure boom, but expansion brings new risks
- China demonstrates novel net-catch rocket recovery system as it races to close the gap with SpaceX
- China turns to molten salt to tackle renewable energy storage bottlenecks in the national grid
- Dramatic slowdown in China’s range-extended electric vehicle market raises concerns over Xiaomi’s strategy
- Biokin’s new cancer drug secures historic approval in China, but Western regulatory hurdles loom
